Systemic Immune Inflammation Index: A Novel Predictor of Contrast-Induced Nephropathy in Patients With Non-ST Segment Elevation Myocardial Infarction.
Adult
Aged
Blood Platelets
Contrast Media
/ administration & dosage
Female
Humans
Inflammation
/ blood
Kidney Diseases
/ blood
Lymphocyte Count
Lymphocytes
Male
Middle Aged
Neutrophils
Non-ST Elevated Myocardial Infarction
/ blood
Patient Admission
Percutaneous Coronary Intervention
/ adverse effects
Platelet Count
Predictive Value of Tests
Retrospective Studies
Risk Assessment
Risk Factors
Time Factors
Treatment Outcome
contrast-induced nephropathy
non-ST segment elevation myocardial infarction
percutaneous coronary intervention
systemic immune inflammation index
Journal
Angiology
ISSN: 1940-1574
Titre abrégé: Angiology
Pays: United States
ID NLM: 0203706
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
pubmed:
9
4
2021
medline:
5
10
2021
entrez:
8
4
2021
Statut:
ppublish
Résumé
We investigated whether the systemic immune inflammation index (SII) on admission is an independent risk factor that predicts the development of contrast-induced nephropathy (CIN) in patients with non-ST segment elevation myocardial infarction (NSTEMI) who underwent percutaneous coronary intervention (PCI). A total of 429 patients with NSTEMI were enrolled in the study. Contrast-induced nephropathy was defined as an increase in serum creatinine level of ≥0.5 mg/dL or ≥25% above baseline within 72 hour after the procedure. Patients were divided into 2 groups: with and without CIN. Demographics, clinical risk factors, angiographic and laboratory parameters, CIN incidence, and SII score were compared between the 2 groups. Non-ST segment elevation myocardial infarction patients, who developed CIN, had higher glucose levels (
Identifiants
pubmed: 33827291
doi: 10.1177/00033197211007738
doi:
Substances chimiques
Contrast Media
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
889-895Commentaires et corrections
Type : CommentIn